|

Allogeneic cytomegalovirus-specific T cells Clinical Trials

1 actively recruiting trial

Also known as: CYT-101

Pipeline

Phase 1/2: 1

Top Sponsors

  • Queensland Institute of Medical Research1

Indications

  • Astrocytoma, Grade IV1
  • Glioblastoma Multiforme1
  • Cancer1

Other1 trial

T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.